The variability of judicial decisions in the stem cell industry in China.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 37802035.
- Also identified by DOI 10.1016/j.stem.2023.09.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As China's stem cell industry continues to develop, increasing disputes concerning stem cell-based interventions have been brought before the courts. Nonetheless, there is variability in the courts' understanding and attitude toward the regulatory attributes of these interventions, which to some extent has multifaceted impacts on the stem cell field.
Medical subject headings
- Stem Cell Research